- Home
- XERS vs SMWB Comparison
XERS vs SMWB Comparison
Compare XERS & SMWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- SMWB
- Stock Information
- Founded
- XERS 2005
- SMWB 2007
- Country
- XERS United States
- SMWB Israel
- Employees
- XERS N/A
- SMWB N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- SMWB Computer Software: Programming Data Processing
- Sector
- XERS Health Care
- SMWB Technology
- Exchange
- XERS Nasdaq
- SMWB Nasdaq
- Market Cap
- XERS 752.7M
- SMWB 695.0M
- IPO Year
- XERS 2018
- SMWB 2021
- Fundamental
- Price
- XERS $5.49
- SMWB $7.84
- Analyst Decision
- XERS Strong Buy
- SMWB Strong Buy
- Analyst Count
- XERS 6
- SMWB 8
- Target Price
- XERS $6.25
- SMWB $14.38
- AVG Volume (30 Days)
- XERS 1.8M
- SMWB 412.9K
- Earning Date
- XERS 08-07-2025
- SMWB 08-12-2025
- Dividend Yield
- XERS N/A
- SMWB N/A
- EPS Growth
- XERS N/A
- SMWB N/A
- EPS
- XERS N/A
- SMWB N/A
- Revenue
- XERS $222,551,000.00
- SMWB $258,017,999.00
- Revenue This Year
- XERS $35.31
- SMWB $16.87
- Revenue Next Year
- XERS $19.65
- SMWB $14.96
- P/E Ratio
- XERS N/A
- SMWB N/A
- Revenue Growth
- XERS 29.88
- SMWB 15.06
- 52 Week Low
- XERS $2.10
- SMWB $5.71
- 52 Week High
- XERS $6.07
- SMWB $17.64
- Technical
- Relative Strength Index (RSI)
- XERS 62.75
- SMWB 42.17
- Support Level
- XERS $4.94
- SMWB $7.89
- Resistance Level
- XERS $5.22
- SMWB $9.03
- Average True Range (ATR)
- XERS 0.22
- SMWB 0.35
- MACD
- XERS -0.01
- SMWB -0.11
- Stochastic Oscillator
- XERS 86.44
- SMWB 6.93
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About SMWB Similarweb Ltd.
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.